Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spain
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spain
Authors
Keywords
-
Journal
ADVANCES IN THERAPY
Volume 35, Issue 11, Pages 1920-1934
Publisher
Springer Nature America, Inc
Online
2018-10-16
DOI
10.1007/s12325-018-0813-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- What do we know about the diagnostics, treatment and epidemiology of Clostridioides ( Clostridium ) difficile infection in Europe?
- (2018) Elisabeth Nagy JOURNAL OF INFECTION AND CHEMOTHERAPY
- Impact of recurrent Clostridium difficile infection: hospitalization and patient quality of life
- (2017) Mark H. Wilcox et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Systematic Literature Review of Economic Evaluations of Antibiotic Treatments for Clostridium difficile Infection
- (2017) Hannah E. Burton et al. PHARMACOECONOMICS
- Antibodies to Toxin B Are Protective AgainstClostridium difficileInfection Recurrence
- (2016) Swati B. Gupta et al. CLINICAL INFECTIOUS DISEASES
- First recurrence of Clostridium difficile infection: clinical relevance, risk factors, and prognosis
- (2016) T. Larrainzar-Coghen et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Recurrent Clostridium difficile infection is associated with increased mortality
- (2015) M.A. Olsen et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options
- (2015) Masako Mizusawa et al. DRUGS & AGING
- Impact of clinical awareness and diagnostic tests on the underdiagnosis of Clostridium difficile infection
- (2015) L. Alcalá et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Risk Factors for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-Analysis
- (2015) Abhishek Deshpande et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Long-term outcomes of colectomy surgery among patients with ulcerative colitis
- (2015) Carl Brown et al. SpringerPlus
- Clostridium difficileInfection in Liver Transplant Recipients: A Retrospective Study of Rates, Risk Factors and Outcomes
- (2014) C. Mittal et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Humoral immune response as predictor of recurrence in Clostridium difficile infection
- (2014) M.P. Bauer et al. CLINICAL MICROBIOLOGY AND INFECTION
- Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID)
- (2014) Kerrie A Davies et al. LANCET INFECTIOUS DISEASES
- Risk Factors for Recurrence, Complications and Mortality in Clostridium difficile Infection: A Systematic Review
- (2014) Claire Nour Abou Chakra et al. PLoS One
- European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection
- (2013) S.B. Debast et al. CLINICAL MICROBIOLOGY AND INFECTION
- Infecciones producidas por Clostridium difficile
- (2013) Dolors Rodríguez-Pardo et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Epidemiology of Clostridium difficile Infection and Risk Factors for Unfavorable Clinical Outcomes: Results of a Hospital-Based Study in Barcelona, Spain
- (2013) D. Rodriguez-Pardo et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Consequences of Clostridium difficile infection: understanding the healthcare burden
- (2012) E. Bouza CLINICAL MICROBIOLOGY AND INFECTION
- Can we identify patients at high risk of recurrent Clostridium difficile infection?
- (2012) C.P. Kelly CLINICAL MICROBIOLOGY AND INFECTION
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
- (2010) Stuart H. Cohen et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- The role of toxin A and toxin B in Clostridium difficile infection
- (2010) Sarah A. Kuehne et al. NATURE
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)
- (2009) M.P. Bauer et al. CLINICAL MICROBIOLOGY AND INFECTION
- Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)
- (2009) Brett A. Leav et al. VACCINE
- Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
- (2008) K.W. Garey et al. JOURNAL OF HOSPITAL INFECTION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now